FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
From - Diagnostic Testing & Emerging Technologies
One in 20 patients without clinical suspicion of acute myocardial infarction has a high sensitivity cardiac troponin I (hs-cTnI) level greater than…
From - Diagnostic Testing & Emerging Technologies
Serial measurement of high-sensitivity C-reactive protein (hsCRP) levels following acute coronary syndrome may help…
From - Diagnostic Testing & Emerging Technologies
The American Society of Clinical Oncology endorsed the American Pathologists' practice guidelines for human papillomavirus (HPV) testing in…
From - Diagnostic Testing & Emerging Technologies
A laboratory-initiated, online effort to reach cancer patients' relatives coupled with discounted genetic tests can increase rates of cascade testing, according to…
From - Diagnostic Testing & Emerging Technologies
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last…